Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
MBX MBX Biosciences
- 10.410
- +1.420+15.80%
Close Feb 14 16:00 ET
- 10.410
- 0.0000.00%
Post 20:01 ET
347.88MMarket Cap-6.30P/E (TTM)
10.490High9.030Low242.97KVolume9.030Open8.990Pre Close2.42MTurnover2.38%Turnover RatioLossP/E (Static)33.42MShares27.50052wk High1.28P/B106.18MFloat Cap8.63152wk Low--Dividend TTM10.20MShs Float27.500Historical High--Div YieldTTM16.24%Amplitude8.631Historical Low9.946Avg Price1Lot Size
About MBX Biosciences Company
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Company Profile
SymbolMBX
Company NameMBX Biosciences
Listing DateSep 13, 2024
Issue Price16.00
Founded2018
CEOMr. Peter Kent Hawryluk
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
Address11711 North Meridian Street,Suite 300
CityCarmel
ProvinceIndiana
CountryUnited States of America
Zip Code46032
Phone1-317-659-0200
Websitehttp://www.mbxbio.com
Company Executives
- Name
- Position
- Salary
- Peter Kent Hawryluk
- President, Chief Executive Officer and Director
- 4.86M
- Dr. Salomon Azoulay, M.D.
- Chief Medical Officer
- --
- Richard B. Bartram
- Chief Financial Officer and Principal Accounting Officer
- 1.05M
- James M. Cornelius
- Independent Director
- --
- Edward T. Mathers
- Independent Director
- --
- Dr. Tiba Aynechi, PhD
- Independent Director
- --
- Dr. Steven Ryder, M.D.
- Independent Director
- --
- Dr. Ora H. Pescovitz, M.D.
- Independent Director
- --
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- --
- Patrick J. Heron
- Independent Director
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
